hydronidone
Small moleculeexperimental
Clinical trial activity
10 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Jul 1, 2015 (NCT02499562)
Timeline
Indications
Mechanism of action
- Growth/differentiation factor 15INHIBITOR
GDF15 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
Cc1ccc(=O)n(-c2ccc(O)cc2)c1- Mol. weight
- 201.22 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297288 ↗
Also known as
- hydronidone
- hydronidone
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07262346 | Phase 1 | Dec 5, 2025 | GNI Group, Huazhong University of Science and Technology |
| NCT07263152 | Phase 1 | Dec 1, 2025 | GNI Group |
| NCT07262333 | Phase 1 | Dec 1, 2025 | GNI Group, Huazhong University of Science and Technology |
| NCT05905172 | Phase 3 | Jun 20, 2023 | Capital Medical University, GNI Group, Jiao Tong University |
| NCT05115942 | Phase 3 | Nov 20, 2021 | Capital Medical University, GNI Group, Jiao Tong University |
| NCT04123769 | Phase 1 | Sep 3, 2019 | GNI Group |
| NCT04162821 | Phase 1 | Jun 26, 2019 | GNI Group |
| NCT04124081 | Phase 1 | May 15, 2019 | GNI Group |
| NCT04125056 | N/A | Jan 16, 2019 | GNI Group |
| NCT02499562 | Phase 2 | Jul 1, 2015 | Jiao Tong University, Shanghai Genomics, Inc. |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GNI Group | For profit | 9 | 9 | 3 | 2019 |
| Jiao Tong University | Academic/Hospital | 3 | 0 | 2 | 2015 |
| Capital Medical University | Academic/Hospital | 2 | 0 | 1 | 2021 |
| Huazhong University of Science and Technology | Academic/Hospital | 2 | 0 | 1 | 2025 |
| Shanghai Genomics, Inc. | For profit | 1 | 1 | 1 | 2015 |
5 organizations
Page 1 / 1